Cardiovascular
Pharmacology
Welcome! This is your complete guide to CV drugs โ taught as Dr. Amiyangoda would explain it to you from scratch. We start with why the heart needs these drugs, then learn each drug family using the exam formula.
The Formula โ Learn This First
What You'll Master
Vascular Tone Drugs
ACE inhibitors, ARBs, Calcium channel blockers, Nitrates, Catecholamines, ARNIs
Antiarrhythmics
Vaughan-Williams Classes 0โ4 with key drugs: amiodarone, lidocaine, digoxin, adenosine
Inotropes
Digoxin, dobutamine, PDE inhibitors, levosimendan โ for failing hearts
Coagulation Drugs
Anticoagulants (heparin, warfarin, DOACs) + antiplatelets + thrombolytics
Diuretics
Loop, thiazide, Kโบ-sparing, osmotic, carbonic anhydrase inhibitors โ where each works in the nephron
Clinical Scenarios
Real patient cases โ choose the right drug and explain why. Exam-style practice.
Begin with Chapter 01: Vascular Tone
Drugs Influencing Vascular Tone
Vascular tone = how tight or relaxed your blood vessels are. It determines blood pressure and how hard the heart works. These drugs are the backbone of hypertension and heart failure treatment.
๐ง The Big Picture First
Vascular smooth muscle contracts when Caยฒโบ enters โ activates MLCK โ myosin phosphorylation โ contraction. It relaxes when cGMP/cAMP increases or Caยฒโบ is blocked.
๐ This is what ACE inhibitors and ARBs block. Block different steps, same result: vasodilation.
Drug Families
Mechanism
ACE inhibitors block the Angiotensin Converting Enzyme โ the enzyme that converts AT-I โ AT-II. Less AT-II means:
- โLess vasoconstriction โ lower blood pressure
- โLess aldosterone โ less Naโบ/water retention
- โMore bradykinin (not broken down) โ extra vasodilation
- โ That same bradykinin causes the infamous dry cough
Key Drugs
Uses
Adverse Effects & Why NOT
๐ Quick Reference: All Vascular Tone Drugs
| Drug class | Mechanism | Main use | Key adverse effect / CI |
|---|---|---|---|
| ACE inhibitors | Block ACE โ โAT-II | HTN, HF, post-MI, DM nephropathy | Dry cough, angioedema, pregnancy CI |
| ARBs | Block ATโ receptor | Same as ACEi (no cough) | Pregnancy CI, hyperkalaemia |
| CCB (DHP) | Block L-type Caยฒโบ (vascular) | HTN, stable angina | Ankle oedema, flushing, reflex tachycardia |
| CCB (non-DHP) | Block Caยฒโบ (cardiac + vascular) | SVT, rate control in AF | Bradycardia, heart block โ NEVER with ฮฒ-blockers |
| Nitrates | โ NO โ โcGMP โ venodilation | Angina (acute & prophylaxis) | Nitrate tolerance, CI with PDE5 inhibitors |
| ARNI | Neprilysin inh + ARB | HFrEF (replaces ACEi) | CI: with ACEi (โโangioedema risk) |
Antiarrhythmic Drugs
Arrhythmias = abnormal heart rhythms. These drugs work by modifying ion channel activity to restore normal rhythm. The Vaughan-Williams classification is the key you need.
๐ง Why do arrhythmias happen?
Normal cardiac rhythm depends on precise ion flow. Arrhythmias occur due to: (1) Abnormal automaticity โ cells firing when they shouldn't, (2) Re-entry circuits โ impulse going round in circles, (3) Triggered activity โ afterdepolarisations.
Vaughan-Williams Classification
Class 0 โ HCN Channel Blockers
IvabradineBlocks the funny current (If) in the SA node โ slows pacemaker rate. Reduces heart rate WITHOUT affecting contractility. Used in stable angina/heart failure when ฮฒ-blockers can't be used.
Class 1 โ Naโบ Channel Blockers
Class 2 โ Autonomic Modulators
Block ฮฒโ โ โSA node rate, โAV conduction. Used for AF rate control, post-MI, heart failure (chronic). CI: asthma (use cardioselective), decompensated HF
Digoxin: vagal โ โAV conduction, used for AF rate control. Adenosine: IV bolus โ transiently blocks AV node, diagnosis/termination of SVT. Very short half-life (10s).
Class 3 โ Kโบ Channel Blockers (Amiodarone โ learn this well!)
- โ Used for SVT, VT, AF cardioversion
- โ Highly lipophilic โ huge volume of distribution
- โ Half-life up to 5 MONTHS (amiodarone lasts forever!)
- โ Toxicity: pulmonary fibrosis, thyroid dysfunction (both hyper/hypo), liver damage, corneal deposits, photosensitivity
- โ Monitor: TFTs, LFTs, PFTs, CXR, eye exam
Class 4 โ Caยฒโบ Channel Blockers (cardiac)
Verapamil & Diltiazem โ block L-type Caยฒโบ in SA/AV nodes โ โheart rate, โAV conduction. Used for SVT, AF rate control.
๐ซ NEVER combine with ฮฒ-blockers โ risk of complete heart block and cardiac arrest
๐ฌ Digoxin โ The Classic Drug
Mechanism
- Inhibits Naโบ/Kโบ-ATPase pump
- โ intracellular Naโบ โ less Caยฒโบ expelled
- โ intracellular Caยฒโบ โ stronger contraction (positive inotrope)
- Also increases vagal tone โ โ AV conduction (rate control in AF)
Toxicity (very important!)
- โข Nausea, vomiting, visual disturbances (yellow halos)
- โข Arrhythmias (bradycardia, heart block, VT)
- โข Hypokalaemia WORSENS toxicity (diuretics + digoxin = dangerous!)
- โข Narrow therapeutic window โ monitor drug levels
- โข Antidote: Digibind (anti-digoxin antibody fragments)
Inotropic Drugs
These drugs increase myocardial contractility โ the force of the heartbeat. Used when the heart can't pump adequately (heart failure, cardiogenic shock).
๐ง One Principle: Increase Intracellular Caยฒโบ
All inotropes work by getting more Caยฒโบ available to cardiac myofilaments. They do this through different routes:
๐ Dobutamine
- Class: Synthetic catecholamine, ฮฒโ agonist
- Route: IV infusion only
- Use: Acute decompensated heart failure, cardiogenic shock
- Caution: Causes tachycardia and arrhythmias at high doses
- CI: Hypertrophic obstructive cardiomyopathy
๐ PDE Inhibitors (Milrinone, Enoximone)
- Mechanism: Inhibit phosphodiesterase 3 โ โcAMP โ โcontractility + vasodilation ("inodilatators")
- Use: Short-term acute HF
- Key point: Long-term use increases mortality โ only for bridge therapy
- AE: Hypotension, arrhythmias
๐ Levosimendan โ The Modern Inotrope
- Mechanism: Caยฒโบ sensitiser โ makes myofilaments more sensitive to Caยฒโบ (doesn't increase Caยฒโบ itself)
- Also: Opens K-ATP channels โ vasodilation (lusitropic effect)
- Advantage: Doesn't increase Oโ demand as much as catecholamines
- Use: Acute decompensated HF where dobutamine insufficient
- Route: IV infusion, single dose (24h) โ effects last days due to active metabolite
- AE: Hypotension, headache, tachycardia
Drugs Used in Coagulation
Three groups: Anticoagulants (prevent clot formation), Antiplatelets (prevent platelet aggregation), Thrombolytics/Fibrinolytics (dissolve existing clots).
1. Anticoagulants
The Big 3: Heparin vs Warfarin vs DOACs
| Property | Heparin (UFH) | LMWH (Enoxaparin) | Warfarin | DOACs |
|---|---|---|---|---|
| Mechanism | Activates antithrombin โ inhibits IIa + Xa | Activates antithrombin โ mainly Xa | Inhibits Vit K epoxide reductase โ โII, VII, IX, X | Direct Xa (rivaroxaban) or IIa (dabigatran) |
| Route | IV / SC | SC (once daily) | Oral | Oral |
| Monitoring | aPTT | Anti-Xa (usually not needed) | INR (target 2-3) | Usually not needed |
| Reversal | Protamine sulphate | Protamine (partial) | Vitamin K + FFP/PCC | Idarucizumab (dabigatran); Andexanet alfa (Xa) |
| Pregnancy? | โ Safe (doesn't cross placenta) | โ Safe | โ Teratogenic in T1, bleeding T3 | โ Avoid |
2. Antiplatelet Drugs
Aspirin
Irreversibly inhibits COX-1 โ โTXAโ (platelet aggregant). Low dose (75mg) for antiplatelet effect.
Clopidogrel (P2Y12 blocker)
Irreversibly blocks ADP receptor (P2Y12) on platelets. Prodrug โ requires CYP450 activation (genetic variability!).
GP IIb/IIIa Antagonists
Block the final common pathway of platelet aggregation (fibrinogen bridge). Most potent antiplatelets. IV only.
3. Thrombolytics (Fibrinolytics)
These drugs activate plasminogen โ plasmin โ dissolves fibrin clot. They break down existing clots โ unlike anticoagulants which prevent new ones.
Drugs
- Streptokinase โ bacterial protein, allergic reactions possible, cheaper
- tPA (Alteplase) โ fibrin-specific, preferred in stroke
- Tenecteplase โ single IV bolus, used in STEMI
Uses & Contraindications
Diuretics & Fluid Replacement
Diuretics increase urine output by blocking Naโบ reabsorption at different points in the nephron. The key is knowing WHERE each drug acts.
๐บ๏ธ Where Each Drug Acts in the Nephron
๐ต Loop Diuretics โ Furosemide
- Mechanism: Block NKCC2 cotransporter in thick ascending limb
- Effect: Also lose Caยฒโบ, Mgยฒโบ (lose everything with the loop!)
- โ Pulmonary oedema (IV โ fast), chronic HF, hypertension
- โ Hypercalcaemia (force Caยฒโบ excretion โ with IV saline)
- โ Hypokalaemia, hypomagnesaemia, gout, ototoxicity (high IV dose)
๐ก Thiazides โ HCTZ, Indapamide
- Mechanism: Block NCC cotransporter in DCT
- Unique: Retain Caยฒโบ (useful in hypercalciuria/kidney stones)
- โ First-line for hypertension, CCF
- โ Hypokalaemia, hyperuricaemia (gout), hyperglycaemia
- โ Ineffective if GFR <30 mL/min (except metolazone)
๐ข Kโบ-sparing โ Spironolactone, Amiloride
- Spironolactone: Aldosterone receptor antagonist โ โENaC expression
- Amiloride: Directly blocks ENaC channel
- โ Heart failure (spiro proven to reduce mortality), hyperaldosteronism, oedema with hypokalaemia
- โ Hyperkalaemia โ DANGEROUS with ACE inhibitors/ARBs/Kโบ supplements
- โ Spironolactone: gynaecomastia (anti-androgen effect)
๐ฎ Electrolyte Changes Summary
| Diuretic | Kโบ | Naโบ | Caยฒโบ |
|---|---|---|---|
| Loop | โโ | โ | โ |
| Thiazide | โ | โ | โ (retained) |
| Kโบ-sparing | โ (retained) | โ | โ |
Clinical Scenarios
This is how the exam tests you. Read each case, choose your answer, then reveal the explanation.
Flashcards Practice
Tap to flip. Master the most important facts for your exam.
Quick Quiz
Test your knowledge. No hints โ just like the real exam.